Revision: February 2020
Commonly requested panels are listed below, by kit name. When requesting a panel, please include the MLPA mix and version number (for example P088-C2). If the panel is not in the list, please contact tech_support@softgenetics.com. Many commonly used panels are also available in the Panel Editor of GeneMarker -- Tools - Panel Editor - File - Import Pre-defined Panels - MLPA folder.
Click here to request panels.
| MLPA mix | Known Syndrome / Disease | Chromosomal Area / Genes | |
| ME001-Tumour suppressor mix 1 | Tumour suppressor genes | Various | |
| ME002-Tumour suppressor mix 2 | Tumour suppressor genes | Various | |
| ME003-Tumour suppressor mix 3 | Tumour suppressor genes | Various | |
| ME004-Tumour suppresoor mix 4 | Tumour suppressor genes | Various | |
| ME011-MMR | Mismatch repair genes(MMR) | MLH1, MSH2, MSH6, MLH3, MSH3 | |
| ME012-MGMT | Aberrant methylation | MGMT | |
| ME024-9p21 | Tumours, Cutaneous melanoma | 9p21, CDKN2A, CDKNA2B | |
| ME029-FMR1/AFF2 | Fragile X | FMR1, AFF2 | |
| ME030-BWS/RSS | Beckwith-Wiedemann | 11p15 region, H19, IGF2, | |
| ME031-GNAS | Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP) | GNAS 20q13.32 | |
| ME032-UPD7-UPD14 | Aberrant methylation | GRB10, MEG3, MEST, MIR380, PLAGL1 | |
| ME034 | Multi-locus Imprinting | Various | |
| ME043-Lynch Syndrome | Lynch syndrome | MHL1, MSH2, CDKN2A, BRAF V600E | |
| P002-BRCA1 | Hereditary breast cancer | 17q21.31 | |
| P003-MLH1/MSH2 | Hereditary nonpolyposis colon cancer (HNPCC) | MLH1 3p21.3, MSH2 2p22 | |
| P004-ERBB2 | Cancer | ERBB2 (HER2-NEU)17q21.1 | |
| P008-PMS2 | Hereditary nonpolyposis colon cancer (HNPCC) | PMS2 7p22 | |
| P010-POLG | Mitochondrial maintenance | POLG, POLG2, C10orf2 (PEO1), SLC25A4 (ANT1) | |
| P011-VWF mix 1 | Von Willebrand Disease(vWD) | vWF 12p13 | |
| P012-VWF mix 2 | Von Willebrand Disease(vWD) | vWF 12p13 | |
| P013-ATRX | Alpha-Thalassemia MentalRetardation | ATRX ; Xq13 | |
| P014-Chromosome 8 | Tumour research | Chromosome 8 | |
| P015-MECP2 | RETT syndrome | MECP2, Xq28 | |
| P016-VHL | Von Hippel-LindauSyndrome | VHL, 3p25 | |
| P017-MEN1 | Multiple endocrine neoplasia | MEN1 11q13 | |
| P018-SHOX | Idiopathic growth retardation | SHOX-Xp22 | |
| P020 | |||
| P021-SMA | Spinal Muscular Atrophy(SMA) | SMN1, SMN2, 5q13 | |
| P022 -PLP1 | Pelizaeus-Merzbacher disease (PMD) | PLP1 Xq22 | |
| P025-Canavan | Canavan disease | ASPA, 17p13 | |
| P026-Sotos | Sotos syndrome | NSD1, 5q35 | |
| P027-Uveal | Uveal Melanoma | 1p, 3, 6p, 8q (MYC region) | |
| P028-FHL | Familial lymphohistiocytosis(HLH) | UNC13D 17q25.1, PRF110q22.1, STX11 6q24.2 | |
| P029-WBS | Williams-Beuren syndrome | WBS criticial region 7q11.23 | |
| P031-FANCA mix 1 | Fanconi Anemia (FA) | FANCA 16q24.3 | |
| P032-FANCA mix 2 | Fanconi Anemia (FA) | FANCA 16q24.3 | |
| P033-CMT1 | Charcot-Marie Tooth disease (CMT1), Hereditary Neuropathy with liability to Pressure Palsies (HNPP) | CMT1/HNPP region,17p11.2 | |
| P034-DMD-1 | Duchenne MuscularDystrophy (DMD) | DMD, Xp21.2 | |
| P035-DMD-2 | Duchenne MuscularDystrophy (DMD) | DMD, Xp21.2 | |
| P036-Human Telomere-3 | Broad subtelomeric screening | All subtelomeres | |
| P037-CLL-1 | Chronic LymphocyticLeukemia (CLL) | Various | |
| P038-CLL-2 | Chronic LymphocyticLeukemia (CLL) | Various | |
| P040-CLL | Chronic LymphocyticLeukemia (CLL) | Various | |
| P041-ATM-1 | Ataxia-Telangiectasia (AT) | ATM 11q23 | |
| P042-ATM-2 | Ataxia-Telangiectasia (AT) | ATM 11q23 | |
| P043-APC | Hereditary Polyposis ColonCancer | APC, 5q21-q22 | |
| P044-NF2 | Neurofibromatosis type 2 (NF2) | NF2 22q12 | |
| P045-BRCA2/CHEK2 | Breast cancer, hereditary | BRCA2, CHEK2 | |
| P046-TSC2 | Tuberous Sclerosis | TSC2 16p13.3 | |
| P047-RB1 | Retinoblastoma (RB) | RB1 13q14 | |
| P048-LMNA/MYOT/ZMPSTE24 | Laminopathies, Limb-girdle muscular dystrophy, Myofibrillar myopathies | LMNA 1q21.2-1q21.3 | |
| P049-SLC6A8 - ABCD1 | Creatine transporter, x- linked | SLC6A8, Xq28 | |
| P050-CAH | Congenital AdrenalHyperplasia | CYP21A2 6p21.3 | |
| P051-Parkinson mix 1 | Parkinson disease, familial | PARK2 6q25.2, SNCA4q21, Pink1, Park7 1p36 | |
| P052-Parkinson mix 2 | Parkinson disease, familial | PARK2 6q25.2, UCHL1 | |
| P054-FOXL2-TWIST1 | Ophthalmogenetic anomalies | FOXL2 , TWIST1, FOXC1, FOXC2, ATR, PITX2, GPR143 | |
| P055-PAH | Phenylketonuria | PAH 12q24.1 | |
| P056-TP53 | Li-Fraumeni syndrome(LFS) | P53 17q13.1 | |
| P057-FANCD2-PALB2 | Fanconi anemia (FA) | FANCD2. 3p25.3, PALB216p12 | |
| P058-IGHMBP2 | Distal spinal muscular atrophy 1 (DSMA1), SMARD1, dHMN6 | IGHMBP2 11q13 | |
| P059-Dystonia | Dystonia | ||
| P060-SMA | Spinal Muscular Atrophy(SMA) | SMN1, SMN2, 5q13 | |
| P061-Lissencephaly | Lissencephaly | LIS1, DCX, POMT1, POMGnT1, FLNA | |
| P062-LDLR | Hypercholesterolemia, familial | LDLR 19p13.2 | |
| P064-MR-1 | Mental Retardation; 1p- deletion, Williams, Smith- Magenis, Miller-Dieker, DiGeorge, Prader-Willi, Alagille, Saethre-Chotzen, Sotos | Various | |
| P065-Marfan-1 | Marfan syndrome | FBN1 15q21.1, TGFBR23p22 | |
| P066-Marfan-2 | Marfan syndrome | FBN1 15q21.1 | |
| P067-PTCH | Gorlin syndrome | PTCH 9q22.3 | |
| P070-Human Telomere-5 | Broad subtelomeric screening | All subtelomeres | |
| P071-LMNB1-PLP1 | Leukodystrophy | LMNB1 5q23.2, PLP1Xq22.2, NOTCH3 19p13.12 | |
| P072-MSH6 | Hereditary nonpolyposis colon cancer (HNPCC) | MSH6 | |
| P074-AR | Androgen insensitivity syndrome (AIS) | AR Xq12 | |
| P073-IKBKG | Incontinentia Pigmenti | Xq28 | |
| P075-TCF4-FOXG1 | Pitt-Hopkins syndrome, Congential variant of Rett syndrome | TCF4, FOXG1 | |
| P076-ACADVL-SLC22A5 | VLCAD/Primary Carnitine | ACADVL, SLC22A5 | |
| P077-BRCA2 | Breast cancer, hereditary | BRCA2 | |
| P078-Breast tumour | Breast tumour | various | |
| P079-OTC | Ornithine cabamoyltransferase (OTC) | OTC Xp21.1 | |
| P080-Craniofacial | Craniofacial disorders | FGFRs, TWIST, MSX2, ALX4, RUNX2 | |
| P081-NF1 mix 1 | Neurofibromatosis | NF1 17q11.2 | |
| P082-NF1 mix 2 | Neurofibromatosis | NF1 17q11.2 | |
| P083-CDH1 | CDH1 or E-cadherin | CDH1 16q22.1 | |
| P087-BRCA1 | Breast cancer, hereditary | BRCA1 | |
| P088-Oligodendroglioma | Oligodendroglioma | 1p, 19q | |
| P089-TK2 | mtDNA depletion syndrome | TK2, MPV17, DGUOK, RRM2B, SUCLA2, SUCLG1 | |
| P090-BRCA2 | Breast cancer, hereditary | BRCA2 13q12.3 | |
| P091-CFTR | Cystic Fibrosis | CFTR 7q31.2 | |
| P092-ABCC6 | Pseudoxanthoma elasticum | ABCC6 16p13.1 | |
| P093-HHT/PPH1 | Hemorrhagic telangiectasia, hereditary (HHT), Primary pulmonary hypertension (PPH1) | ENG 9q34.1, ALK112q13.13, BMPR2 2q33.3 | |
| P094-MEFV | Mediterranean fever, familial(MEFV) | MEFV 16p13.3 | |
| P095-Aneuploidy | Down syndrome, Edwards syndrome, Patau syndrome | Chr. 13, 18, 21, X, Y | |
| P096-MR-2 | Mental retardation, Wolf- Hirschlorn, Cri du Chat, Langer-Giedon, WAGR, Rubinstein-Taybi, Down, Kabuki | Various | |
| P098-Wilson | Wilson disease | ATP7B 13q14.3 | |
| P099-GCH1-TH-SGCE | Dopa-responsive dystonia, Segawa disease; Myoclonus-dystonia syndrome | TH 11p15.5, GCH114q22, SGCE 7q21 | |
| P100-MYBPC3 | Hypertrophic cardiomyopathy, familial | MYBPC3 11p11.2 | |
| P101-STK11 | Peutz-Jeghers syndrome(PJS) | STK11 19p13.3 | |
| P102-HBB | Thalassemia, beta-zero | HBB 11p15.5 | |
| P103-DPYD | Dihydropyrimidine dehydrogenase (DPYD) deficiency | DPYD 1p22 | |
| P104-Menkes ATP7A | Menkes disease | ATP7A Xq13.3 | |
| P105-Glioma-2 | Glioma, malignant | EGFR, TP53, PTEN +various other | |
| P106-MRX | Mental retardation, x-linked(XLMR) | Chromosome X | |
| P107-Neurometabolic | Neurometabolic disorders | ASPA, MLC1, MLYCD, D2HGDH, L2HGDH | |
| P108-SCN5A | Brugada / long QT | SCN5A 3p22 | |
| P109-ABCB4 | Drug-transport pump | ABCB4 7q21,1 | |
| P110-FCGR mix 1 | FCGR genes 1q23.3 | FCGR genes 1q23.3 | |
| P111-FCGR mix 2 | FCGR genes 1q23.3 | FCGR genes 1q23.3 | |
| P112-PROS1 | PROS1 deficiency | PROS1 3q11.2 | |
| P113-FANCB | Fanconi anemia complementation group B | FANCB Xp22 | |
| P114-Long-QT | Congenital long QTsyndrome (LQT) | KCNQ1 11p15.5, KCNH27q35 | |
| P116-SGC | Limb-girdle muscular dystrophy (LGMD) | SGCA, SGCB, SGCD, SGCG, FKRP | |
| P117-ABCC8 | Hyperinsulinemic hypoglycemia, familial (HHF1) | ABCC8 11p15.1 | |
| P118-WT1 | Wilms tumours, WAGR, Denys-Drash, Frasier syndrome. | WT1 11p13 | |
| P120-PANK2/PLA2G6 | Neurodegeneration with brain iron accumulation (NBIA) | PANK2 20q13, PLA2G622q13 | |
| P122-NF1-area | Neurofibromatosis | NF1 17q11.2 | |
| P124-TSC1 | Tuberous Sclerosis | TSC1 9q34 | |
| P125-Mitochondria | Mitochondrial DNA (mtDNA) | Mitochondria | |
| P128-CYP450 | Cytochrome P-450 | CYP2D6, CYP2C9, CYP2C19, CYP1B1, | |
| P130-CCM mix-A | Cerebral CavernousMalformations (CCM) | CCM 7q21 | |
| P131-CCM mix-B | Cerebral CavernousMalformations (CCM) | CCM 7q21 | |
| P132-Kallmann-1 | Kallmann syndrome, x- linked | KAL1 Xp22 | |
| P133-Kallmann-2 | Kallmann syndrome | FGFR1 8p11.2, GNRHR8p21, KISSR1 19p13.3 , GNRH1, NELF 9q34.3 | |
| P136-Gitelman | Gitelman syndrome | SLC12A3 16q13 | |
| P137-SCN1A | Epilepsy | SCN1a 2q24.3 | |
| P138-SLC2A1 | Glut1 deficiency syndrome | SLC2A1 1p34.2 | |
| P140-HBA | Thalassemias, Alpha | HBA 16p | |
| P141-NIPBL-1 | Cornelia de Lange syndrome (CDLS) | NIPBL 5q13.1 | |
| P142-NIPBL-2 | Cornelia de Lange syndrome (CDLS) | NIPBL 5q13.1 | |
| P143-MFN2-MPZ | Charcot-Marie-Tooth disease (CMT2A/1B) | MFN2 1p36.2, MPZ 1q22 | |
| P147-1p36 | 1p36 deletion syndrome | 1p36 | |
| P148-TGFBR1-TGFBR2 | Aortic aneurysm syndrome | TGFBR1 9q22, TGFBR23p22 | |
| P149-CYP4V2 | Crystalline Corneoretinal | CYP4V2 | |
| P151-ABCA4 mix-1 | Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration | ABCA4 (ABCR) 1p22.1 | |
| P152-ABCA4 mix-2 | Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration | ABCA4 (ABCR) 1p22.1 | |
| P153-EYA1 | Branchio-oto-renal dysplasia syndrome (BOR) | EYA1 8q13.3. | |
| P154-GPC3-GPC4 | Simpson-Golabi-Behmel syndrome (SGBS) | GPC3, GPC4, Xq26 | |
| P155-EDS | The Ehlers-Danlos syndrome type III (EDS III) | COL3A1 2q31, TNXB6p21.3. | |
| P156-GALT | Classic galactosemia | GALT 9p13 | |
| P158-JPS | Juvenile polyposis syndrome (JPS) | BMPR1A 10q22, SMAD418q21, PTEN | |
| P159-GLA | Fabry Disease | GLA Xq22 | |
| P160-STS | Steroid Sulfatase gene(STS) | STS Xp22 | |
| P163-GJB-WFS1 | Hearing loss | GJB 1p35.1 (connexin 31), WFS1 4p16.1 (Wolframin) | |
| P164-IDS | Mucopolysaccharidosis typeII, or Hunter syndrome | IDS Xq28 | |
| P165-HSP | Spastic paraplegia, hereditary (HSP) | SPG3A 14q21, SPAST2p22 | |
| P166-KCNQ2 | Benign familial neonatal convulsion (BFNC) | KCNQ2 20q13.33 | |
| P168-ARVC-PKP2 | Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) | DSP 6p24, PKP2 12q11.21 | |
| P169-Hirschsprung-1 | Hirschsprung disease, orAganglionic Megacolon | RET 10q11.2, ZFHX1B2q22.3, EDN3 20q13.3 andGDNF 5q13.2 | |
| P170-APP | Alzheimer disease, early- onset | APP 21q21.3 | |
| P175-Tumour-Gain | Tumour-gain | various | |
| P176-CAPN3 | Limb girdle muscular dystrophy 2A (LGMD2A) | CAPN3 15q15.1 | |
| P177-CASR | HypocalciuricHypercalcemia, familial | CASR 3q13 | |
| P178-F8 | Haemophilia A, x-linked | F8 gene, Xq28 | |
| P179-Limb-1 | Limb malformations | GLI3 7p13, HOXD13 2q31, ROR2 9q22 | |
| P180-Limb-2 | Limb malformations, heart | SALL1 16q12, SALL420q13, TBX5 12q24 | |
| P181-Centromere-1 | Centromeric screening | Centromeres | |
| P182-Centromere-2 | Centromeric screening | Centromeres | |
| P183-EDA | Ectodermal dysplasia, x- linked (XLHED) | EDA Xq12-q13.1 | |
| P184-JAG1 | Alagille Syndrome (AGS) | JAG1 20p12.2 | |
| P185-Intersex | Sex determination | SOX9 17q24.3, NR5A19p33, WNT4 1p36.12, NROB1 Xp21.2 | |
| P186-PAX3-MITF-SOX10 | Waardenburg syndrome(WS) type II, WS1, WS3 | PAX3 2q35, MITF 3p14, SOX10 22q13.1 | |
| P187-HPE | Holoprosencephaly (HPE) | PTCH, SHH, ZIC2, SIX3, | |
| P188-22q13 | Phelan-Mcdermid syndrome, Telomeric monosomy 22q13.3 | 22q13.3, SHANK3, ACR, RABL2B | |
| P189-CDKL5 | Rett syndrome, atypical | CDKL5 Xp22, NTNG11p13.3, ARX Xp22.1 | |
| P190-CHEK2 | Breast cancer susceptibility | CHEK2 22q12, ATM , PTEN, TP53 | |
| P191-Alport-mix1 | Alport syndrome, HereditaryNephritis | COL4A5 Xq22 | |
| P192-Alport-mix2 | Alport syndrome, HereditaryNephritis | COL4A5 Xq22 | |
| P193-NPC1 | Niemann-Pick type Cdisease (NPC) | NPC1, NPC2 | |
| P196-TNNT2-BAG3 | Hypertrophic cardiomyopathy familial, Dilated cardiomyopathy | TNNT2 1q32 | |
| P197-KCNQ3 | Neonatal convulsions type2, familial (BFNC2), Epilepsy benign neonatal type 2 (EBN2) | KCNQ3 8q24.22 | |
| P198-FH | Fumarase deficiency (FH) | FH | |
| P199-HEXA | Tay-Sachs Disease | HEXA 15q23 | |
| P200-Reference-1 | Synthetic 'home-made' probes | Reference probes + control fragments | |
| P201-Charge | Charge syndrome | CHD7 8q12.2 | |
| P202-IKZF1 (IKAROS) | Acute lymphoplastic leukemia (ALL), CML | IKZF1 7p12.2 | |
| P203-PKLR | Haemolytic Anaemia, hereditary non-spherocytic | PKLR 1q22 | |
| P205-XLP | Lymphoproliferative syndrome, x-linked (XLP). Duncan disease | SH2D1A Xq25 | |
| P207-F9 | Factor IX deficiency, Christmas disease | F9 Xq27.1 | |
| P208-Human Telomere-6 | Subtelomeric screening | 2p, 3p, 6p, 8p | |
| P209-GLDC | Glycine encephalopathy | GLDC 9p22 | |
| P210-BTK | Agammaglobulinemia | BTK Xq22.1 | |
| P211-HSP region | Hereditary SpasticParaplegias (HSPs) region | SPAST 2p22, NIPA1 15q11 | |
| P212-DBA | Diamond-Blackfan anemia(DBA) | RPS19 19q13.2, 8p23 | |
| P213-HSP2 | Hereditary spastic paraplegias (HSPs) | REEP1 (SPG31) 2p11.2, SPG7 16q24.3 | |
| P214-COL2A1 | Skeletal disorders, Achondrogenesis, Chondrodysplasia, Early onset familial Osteoarthritis, SED congenital, Langer- Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome, Spondyloepimetaphyseal | COL2A1 12q13.11-q13.2 | |
| P215-EXT | Multiple Osteochondromas | EXT1 8q24, EXT2 11p12 | |
| P216-GHD mix1 | Growth Hormone Deficiency(GHD) | GH1, LHX4, POU1F1, HESX1, PROP1, GHRHR, LHX3 | |
| P217-IGF1R | Insulin-like growth factor 1 receptor (IGF1R) | IGFR1, IGFBP3. | |
| P218-LPL | LPL deficiency | LPL 8p21.3 | |
| P219-PAX6 | Ocular malformations, hereditary | PAX6 11p13, SOX2 3q26, WT1, 11p13 | |
| P220-Obesity | Obesity | LEPR, POMC, LEP, SIM1, MC3R, MC4R | |
| P221-LCA mix-1 | Leber congenital amaurosis(LCA) | AIPL1 17p13, CRB1 1q31, CRX 19q13, RPE65 1p31 | |
| P222-LCA mix-2 | Leber congenital amaurosis(LCA) | GUCY2D 17p13.1, RDH1214q24, RPGRIP1 14q11, CEP290 12q21 | |
| P223-PHEX | Hypophosphatemia, x-linked | PHEX Xp22.2, FGF2312p13 | |
| P224-PPARG | Obesity, Diabetes mellitis type II, Familial partial lipodystrophy III, Colon cancer | PPARG 3p25.1 | |
| P225-PTEN | Cancer | PTEN 10q23 | |
| P226-SDH | Paragangliomas (PGL) | SDHD 11q23.1, SDHB1p36.1, SDHC 1q23.3 | |
| P227-SerpinC1 | Antithrombin (III) deficiency | SerpinC1 1q25.1 | |
| P228-TRPS1-EXT1 | Trichorhinophalangeal syndrome type I (TRPS1), Langer-Giedion syndrome (LGS) | TRPS1, EXT1, 8q24 | |
| P229-OPA1 | Macular dystrophy | OPA1 3q28, VMD2 11q13, RDS 6p21.2 | |
| P231-FGF10-FGFR2 | Autosomal dominant lacrimoauriculodentodigital (LADD) | FGF10 5p13, FGFR2 10q26 | |
| P232-FGD1 | Faciogenital dysplasia (FGDY), Aarskog-Scott syndrome | FGD1 Xp11.21 | |
| P233-MID1 | OPITZ syndrome | MID1 Xp22 | |
| P234-GATA4 | Cardiac septal defects | GATA4 8p23, GATA310p15 | |
| P235-Retinitis | Retinitis Pigmentosa | RHO 3q21.3, RP1 8q11.2, IMPDH1 7q32, PRPF3119q13.4 | |
| P236-ARMD mix-1 | Age-related macular degeneration (ARMD) | CFH, CFHR3, CFHR1, CFHR2, 1q23 | |
| P238-DNAH5 | Primary ciliary dyskinesia(PCD) | DNAH5 5p15 | |
| P239-BRCA1 region | Breast cancer | BRCA1 region | |
| P240-BRIP1/CHEK1 | Cancer | BRIP1 17q22, CHEK111q22 | |
| P241-MODY | Maturity-Onset Diabetes of the Young (MODY) | MODY 1, 2, 3; 5 | |
| P242-Pancreatitis | Hereditary Pancreatitis (HP) | PRSS1 7q34, SPINK1 5q32 | |
| P243-SERPING1 | Hereditary angioedema(HAE) | SERPING1 11q12.1 | |
| P244-AIP-MEN1 | Multiple endocrine neoplasia (MEN) | AIP 11q13, MEN1 11q13 | |
| P245-Microdeletion-1 | Microdeletion syndromes | Various | |
| P247-Chemokine-2 | Chemokines | CXCR4, CX3CR1, CCR5, CCR2, CD4, CD209 | |
| P248-MLH1-MSH2 | Colon cancer, hereditary non-polyposis (HNPCC) | MLH1 3p21.3, MSH2 2p21 | |
| P249-Human Telomere-8 | Subtelomeric screening | 17p, 18p, 19p, 20p | |
| P250-DiGeorge | DiGeorge syndrome | 22q11 | |
| P251-NB mix 1 | Neuroblastoma | 1p36, 3p22/3p21.3 and11q23 | |
| P252-NB mix 2 | Neuroblastoma | 2p24.1/MYCN, 2q33,17p13/TP53, 17q | |
| P253-NB mix 3 | Neuroblastoma | Chromosomes 4, 7, 9, 12,14 | |
| P254-PSEN1 | Alzheimer's disease (AD) | PSEN1 14q24.2 | |
| P255-ALDOB | Fructose intolerance | ALDOB 9q21 | |
| P256-FLCN | Birt-Hogg-Dube syndrome | FLCN 17p11, Smith- Magenis syndrome region | |
| P257-TERT-DKC1 | Dyskeratosis congenita(DC) | DKC1 Xq28 | |
| P258-SMARCB1 | Rhabdoid tumors | SMARCB1 22q11.2 | |
| P259-RPS6KA3 | Coffin-Lowry Syndrome(CLS) | RPS6KA3, PQBP1. | |
| P260-PALB2-RAD50-RAD51C | Fanconi Anemia | RAD50 | |
| P262-GHI | Growth HormoneInsensitivity (GHI) | GHR 5p12, JAK2 9q24.1, IGF1 12q23, STAT5B17q21 | |
| P264-Human Telomere-9 | Subtelomeric screening | 1q, 2q, 3q, 4q | |
| P266-CLCNKB | Bartter syndrome | CLCNKB 1p36 | |
| P267-Dandy-Walker | Dandy-Walker Malformation(DWM) | ZIC1, ZIC4 3p2, VLDLR9p24 | |
| P268-DYSF | Limb girdle muscular dystrophies (LGMD) | DYSF 2p13 | |
| P269-FRMD7 | Congenital nystagmus | Xq26 (NYS1 locus), FRMD7 | |
| P271-COL1A1 | Osteogenesis imperfecta(OI) | COL1A1 17q21.3 | |
| P272-COL1A2 | Osteogenesis imperfecta(OI) | COL1A2 7q21.3 | |
| P274-SLC6A5/GLRA1/GLRB | Startle disease, Hyperekplexia | GLRB 4q32.1, GLRA15q33.1, SLC6A5 11p15.1 | |
| P275-MAPT-GRN | Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration, progressive supranuclear palsy | MAPT 17q21 | |
| P277-Human Telomere-10 | Subtelomeric screening | 5q, 6q, 7q, 8q | |
| P278-PCCA | Propionic acidemia | PCCA 13q32 | |
| P279-CACNA1A | Episodic ataxia 2, Familial hemiplegic migraine | CACNA1A | |
| P280-SLC26A4 | Pendred syndrome | SLC26A4 7q31 | |
| P285-LRP5 | Osteopoprosis- pseudoglioma syndrome (OPPS) | LRP5 11q13.4, DKK110q11.2 | |
| P286-Human Telomere-11 | Subtelomeric screening | 9q, 10q, 11q, 12q | |
| P289-LMX1B | Nail patella syndrome (NPS) | LMX1B 9q33 | |
| P292-PCDH15 | Usher syndrome | PCDH15 10q21.1 | |
| P294-Tumour-Loss | Tumour-Loss | various | |
| P295-SPRED1 | SPRED1 | SPRED1 15q14 | |
| P296-aHUS | Hemolytic uremic syndrome, typical (aHUS) | CFH 4q25 | |
| P297-Microdeletion-2 | Microdeletion syndromes | Various | |
| P300-Reference-2 | Synthetic 'home-made' probes | Reference probes + control fragments | |
| P301-Medulloblastoma mix 1 | Medulloblastoma | Chr. 6, Chr. 14, Chr. 16, Chr. 17. | |
| P302-Medulloblastoma mix 2 | Medulloblastoma | Chr. 2, Chr. 3, Chr. 7, Chr. 9 | |
| P303-Medulloblastoma mix 3 | Medulloblastoma | Chr. 1, Chr. 4, Chr. 5, Chr.8, Chr. 10, Chr. 20 | |
| P304-IRF6 | Van der Woude syndrome(VWS) | IRF6 1q32.2 | |
| P305-AGXT | Primary hyperoxaluria, type1 (PH1) & type 2 (PH2) | AGXT, GRHPR | |
| P306-SPG11 | Hereditary spastic paraplegia (HSP or SPG) | SPG11 or KIAA184015q21.1 | |
| P307-SEPT9 | Hereditary neuralgic amyotrophy (HNA) | SEPT9 17q25.3 | |
| P309-MTM1 | Myotubular myopathy, x- linked (XLMTM) | MTM1 Xq28, MTMR1 Xq28 | |
| P310-TCOF1 | Treacher Collins- Franceschetti 1 | TCOF1 | |
| P311-CHD | Congenital Heart Disease(CHD) | GATA4 8p23, NKX2-5 5q35, TBX5 12q24, BMP4 14q22, CRELD1 3p25 | |
| P312-POR | Congenital adrenal hyperplasia (CAH) | P450 oxireductase gene(POR) | |
| P313-CREBBP | Rubinstein-Taybi syndrome(RSTS) | CREBBP 16p13.3 | |
| P315-EGFR | Tumours, solid | EGFR 7p11 | |
| P316-Ataxias | Recessive Ataxias | SETX, APTX, FXN. | |
| P318-Hirschsprung-2 | Hirschsprung disease | PHOX2B, GFRA3, GFRA2, GFRA1, EDNRB, NRTN, PSPN, SOX10 | |
| P320-Human Telomere-13 | Subtelomeric screening | 17q, 18q, 19q, 20q. | |
| P321-VPS13B mix 1 | Cohen syndrome | VPS13B 8q22 | |
| P322-VPS13B mix 2 | Cohen syndrome | VPS13B 8q22 | |
| P323-CDK4-HMGA2-MDM2 | Sarcoma and other tumour types | chromosome 12, MDM2, CDK4 and HMGA2 genes | |
| P324-22q11 mix-2 | 22q11 | 22q11 | |
| P325-OCA2 | oculocutaneous albinism | OCA2 15q13 | |
| P326-LARGE | Walker-Warburg Syndrome | LARGE, FKTN, POMT2 | |
| P327-iAMP21 | ALL, iAMP21, ERG | iAMP21, RUNX1, ERG | |
| P328-EYS | Retinitis Pigmentosa | EYS 6q12 | |
| P329-CRLF2 | ALL | Xp22.33 | |
| P330-PCDH19 | Epilepsy (EFMR) | PCDH1 | |
| P331-COL5A1 MIX-1 | Ehlers-Danlos Syndrome | COL5A1 9q34.3 | |
| P332-COL5A1 MIX-2 | Ehlers-Danlos Syndrome | COL5A1 9q34.3 | |
| P333-EP300 | Rubinstein-Taybi syndrome(RSTS) | EP300 | |
| P334-Gonadal | Gonadal DevelopmentDisorder | DMRT1, CYP17A1, SRD5A2, HSD17B3 | |
| P335-ALL-IKZF1 | ALL | IKZF1, PAX5, ETV6, RB1, BTG1, EBF1, CDKN2A- CDKN2B, Xp22.33 | |
| P336-UBE3A | Angelman | UBE3A, MTHFR, GABRB3, AXIN1 | |
| P337-TSC2 | Tuberous sclerosis | TSC2 gene, 16p13.3 | |
| P339-SHANK3 | Autism Spectrum Disorder | SHANK3 22q13.33 | |
| P340-EHMT1 | 9q subtelomeric deletion syndrome (9qSTDS) or Kleefstra syndrome. | EHMT1 | |
| P341-PKHD1 mix 1 | Polycystic kidney disease, autosomal recessive (ARPKD) | PKHD1 | |
| P342-PKHD1 mix 2 | Polycystic kidney disease, autosomal recessive (ARPKD) | PKHD1 | |
| P343-Autism-1 | Autism | 15q11-13: UBE3A, GABRB3; 16p11; SHANK322q13 | |
| P348-ATP1A2-CACNA1A | Migraine | 1q23 | |
| P350-CLCN1-KCNJ2 | Myotonia congenita, Thomsen's disease, Becker's disease, Andersen-Tawil syndrome | CLCN1, KCNJ2 | |
| P351-PKD1 | Adult polycystic kidney disease | PKD1 | |
| P352-PKD1-PKD2 | Adult Polycystic Kidney | PKD1, PKD2 | |
| P353-CMT4 | autosomal recessive demyelinating form | SH3TC2; NEFL; GDAP1; EGR2; SBF2; MTMR2; PRX | |
| P354-KIT SNAI2 | Piebaldism/KIT | ||
| P355-Microcephaly | Primary Microcephaly | MCPH1, ASPM, | |
| P356-Chromosome 22q | Subtelomeric screening | 22q11, 22q13 | |
| P357-MODY mix-2 | Maturity-Onset Diabetes of the Young (MODY) | MODY 4; 6-10 | |
| P359-PLOD1 | Ehlers Danlos syndrome type VI | 1p36.22 | |
| P360-Y-Chromosome | Y-ChromosomeMicrodeletions | Chromosome Y | |
| P361-USH2A mix 1 | Usher syndrome | USH2A 1q41 | |
| P362-USH2A mix 2 | Usher syndrome | USH2A 1q41 | |
| P365-Human Telomere-14 | Subtelomeric screening | 7p, 15q-cen, 16p, 21q-cen,21q | |
| P366-CHM-RP2-RPGR | Retinitis pigmentosa (RP) | CHM-RP2-RPGR | |
| P367-BEST1-PRPH2 | Macular Dystrophy, Vitelliform | BEST1 (=VDM2), PRPH2 (=RDS) | |
| P368-DCLRE1C | SCID and Omenn syndrome | 10p13; DCLRE1C | |
| P369-Smith-Magenis | Smith-Magenis syndrome | 17p11.2 | |
| P370-BRAF-IDH1-IDH2 | Gliomas | BRAF, IDH1, IDH2 | |
| P371-Microdeletion-5 | Microdeletion follow-up | 2p16, Langer Giedion,9q22, WAGR, 15q24, 17q21 | |
| P372-Microdeletion-6 | Microdeletion follow-up | Sotos, DiGeorge, Rubinstein-Taybi, NF1 | |
| P373-Microdeletion-7 | Microdeletion follow-up | 1p36, 3q29, Wolf- Hirschlorn, Cri du Chat, Phelan-McDermid | |
| P374-Microdeletion-8 | Microdeletion follow-up | 7q11, PWS/AS, Miller- Dieker, Smith-Magenis, RETT | |
| P376-BRCA1ness | BRCA1-like breast cancer profile | various | |
| P377-Hematologic malign. | Hematological malignancies, various | various | |
| P378-MUTYH | Colon cancer, stomach cancer (hereditary) | 1p34 and 15q13 | |
| P379-NRXN1 | Pitt-Hopkins-like syndrome2 | NRXN1 | |
| P381-COL11A1 mix 1 | Marshall, type II Stickler syndromes | COL11A1 | |
| P382-COL11A1 mix 2 | Marshall, type II Stickler syndromes | COL11A1 | |
| P385-DOCK8 | HIES | 9p24.3 | |
| P386-DOCK8 STAT3 | HIES | 17q21.2, 9p24.3 | |
| P387-NPHP1 | Familial juvenile nephronophthisis | NPHP1 2q13 | |
| P389-MLL2 | Kabuki syndrome | MLL2 gene | |
| P391-LAMA2 mix1 | CMD, Merosin-deficient | 6q22.33 | |
| P392-LAMA2 mix2 | CMD, Merosin-deficient | 6q22.33 | |
| P394-MYO5B | Microvillus InclusionDisease (MVID) | MYO5B 18q21.1 | |
| P395-MEF2C-FOXG1 | mental retardation | MEF2C 5q14.3, FOXG114q12 | |
| P396-SHANK2 | Autism-spectrum disorder | SHANK2 11q13.3 | |
| P397-SCN4A-CACNA1S | nondystrophic myotonias and primary periodic paralyses | CACNA1S, SCN4A | |
| P398-CASK | X-linked mental retardation and MICPCH | CASK | |
| P405-CMT1 | Charcot Marie ToothDisease | CMT/HNPP region at 17p12 | |
| P408-ADLTE-LGI1 | Autosomal Dominant Lateral Temporal Lobe Epilepsy, ADLTE | ADAM22, GPR98, KCNA1, KCNA4, KCNAB1, LGI1, PDYN | |
| P409-RASA1 | capillary malformations, Parkes Weber syndrome | RASA1 5q14.3 | |
| P410-GRIN2A GRIN2B | epilepsy, mental retardation | 16p13.2 GRIN2A, 12p13.1GRIN2B | |
| P411-Porphyria mix 1 | Porphyrias | ALAD, HMBS, PPOX | |
| P412-Porphyria mix 2 | Porphyrias | FECH, UROS, UROD, CPOX | |
| P413-CRC LOSS | Colorectal adenoma/carcinoma | 8p, 15q, 17p, 18q | |
| P414-MDS | Myelodysplastic syndromes | 3, 5q,7q, 8q, 11q, 12p, 17, 19, 20q, Y | |
| P417-BAP1 | Melanocytic tumours, mesothelioma | 3p21.1 | |
| P418-MYH7 | Hypertrophic cardiomyopathy | MYH7 14q11.2 | |
| P419-CDKN2A/2B-CDK4 | Familial melanoma | CDKN2A, CDKN2B, CDK4, MITF E318K | |
| P425-MM | Multiple myeloma | various | |
| P426-Cystinuria | Cystinuria and hypotonia-cystinuria syndrome | SLC3A1, PREPL, SLC7A9 | |
| P431-FOXF1 | Alveolar capillary dysplasia with Misalignment of pulmonary veins and Feingold syndrome | FOXF1 | |
| P436-ANO5 | Muscular dystrophy type 2L or Anoctaminopathy | ANO5 | |
| P437-MDS-AML | Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia | GATA2, TERC, TERT, CEBPA, RUNX1 | |
| P444-COL4A4 | Alport syndrome or Hereditary nephritis | COL4A4 | |
| P446-GALC | Krabbe disease | GALC 14q31.3 | |
| P452-PLS3 | X-linked osteoporosis | PLS3 Xq23 | |
| P457-DHCR7 | Smith-Lemli-Opitz syndrome (SLOS) | DHCR7 | |
| P461-DIS | Deafness-infertility syndrome, Autosomal recessive deafness 16 and Autosomal recessive deafness 22 | STRC, CATSPER2, OTOA | |
| P466-CDC73 | Familial primary hyperparathyroidism | CDC73 | |
| P482-DICER1 | DICER1 syndrome | DICER1 | |
| P484-ALPL | Hypophosphatasia | ALPL | |
| X080 Opsin | Cone photoreceptor disorders | OPN1MW |